azomycin has been researched along with Colorectal Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gendoo, DMA; Haibe-Kains, B; Haller, A; Haynes, J; Jaffray, DA; Kreso, A; Leung, C; Lima-Fernandes, E; McKee, TD; Metser, U; O'Brien, CA; Smith, M; Szentgyorgyi, E; Vines, DC; Wang, Y; Wolman, R; Wouters, BG | 1 |
| Biemans, R; Dubois, L; Lambin, P; Lieuwes, NG; Parvathaneni, NK; Peeters, SG; Rami, M; Saraya, R; Supuran, CT; van Kuijk, SJ; Vooijs, M; Vullo, D; Winum, JY; Yaromina, A | 1 |
| Humm, JL; Li, GC; Li, XF; Ling, CC; Russell, J; Sun, X; Urano, M; Xing, L | 1 |
| Kumar, P; McEwan, AJ; Naimi, E; Wiebe, LI | 1 |
| Begg, A; Debucquoy, A; Devos, E; Haustermans, K; Penninckx, F; Sagaert, X; Verstraete, M | 1 |
| de Geus-Oei, LF; Heerschap, A; Kaanders, JH; Krabbe, PF; Lok, J; Oyen, WJ; Punt, CJ; Rijpkema, M; Ruers, T; van der Kogel, AJ; van Laarhoven, HW; Wiering, B | 1 |
| Heerschap, A; Kaanders, JH; Lok, J; Peeters, WJ; Punt, CJ; Rijken, PF; Ruers, TJ; van der Kogel, AJ; van Laarhoven, HW; Wiering, B | 1 |
| Backes, W; Boterberg, T; Bouckenooghe, I; Ceelen, W; De Visschere, M; Demetter, P; Pattyn, P; Peeters, M; Smeets, P; Van Damme, N | 1 |
| Cass, C; Emami, S; Kresolic, Z; Kumar, P; McEwan, AJ; Paproski, R; Wiebe, LI; Yang, J | 1 |
| Egolf, RA; Fitzpatrick, DA; Heindel, ND; Walton, H | 1 |
1 trial(s) available for azomycin and Colorectal Neoplasms
| Article | Year |
|---|---|
Investigation of possible endogenous hypoxia markers in colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cell Hypoxia; Colorectal Neoplasms; Female; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor-Proline Dioxygenases; Male; Microvessels; Middle Aged; Monocarboxylic Acid Transporters; Nitroimidazoles; Procollagen-Proline Dioxygenase; Radiation-Sensitizing Agents; Survival Analysis | 2013 |
9 other study(ies) available for azomycin and Colorectal Neoplasms
| Article | Year |
|---|---|
Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer.
Topics: Animals; Biomarkers; Caspases; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Chemoradiotherapy; Colorectal Neoplasms; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Female; Humans; Hypoxia; Male; Mice; Neoplastic Stem Cells; Nitroimidazoles; Phenotype; Phosphoramide Mustards; Positron-Emission Tomography; Prodrugs; Standard of Care; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2018 |
Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.
Topics: Animals; Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Line, Tumor; Colorectal Neoplasms; Humans; Mice; Nitroimidazoles; Radiation-Sensitizing Agents | 2013 |
Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry.
Topics: Adenocarcinoma; Analysis of Variance; Animals; Cell Hypoxia; Colorectal Neoplasms; Etanidazole; Female; Hydrocarbons, Fluorinated; Hyperthermia, Induced; Immunohistochemistry; Mice; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Transplantation, Heterologous | 2008 |
Synthesis, radiofluorination, and hypoxia-selective studies of FRAZ: A configurational and positional analogue of the clinical hypoxia marker, [18F]-FAZA.
Topics: Antineoplastic Agents; Binding Sites; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Fluorine Radioisotopes; Humans; Hypoxia; Isotope Labeling; Nitroimidazoles; Positron-Emission Tomography; Ribose | 2010 |
Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
Topics: Adult; Aged; Cell Hypoxia; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Carbonic Anhydrases; Cell Hypoxia; Cell Proliferation; Colorectal Neoplasms; Female; Glucose Transporter Type 1; Humans; Idoxuridine; Liver Neoplasms; Male; Middle Aged; Nitroimidazoles | 2006 |
Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.
Topics: Animals; Capillary Permeability; Cell Hypoxia; Cell Line, Tumor; Colorectal Neoplasms; Contrast Media; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Microcirculation; Models, Animal; Nitroimidazoles; Organometallic Compounds; Oxygen; Partial Pressure; Radiation-Sensitizing Agents; Rats; Vascular Endothelial Growth Factor A | 2006 |
Synthesis, transportability and hypoxiaselective binding of 1-beta-D-(5-Deoxy-5-fluororibofuranosyl)-2-nitroimidazole (beta-5-FAZR), a configurational isomer of the clinical hypoxia marker, FAZA.
Topics: Cell Hypoxia; Colorectal Neoplasms; Equilibrative Nucleoside Transporter 1; Equilibrative-Nucleoside Transporter 2; Gamma Rays; HCT116 Cells; Humans; Isomerism; Membrane Transport Proteins; Nitroimidazoles; Radiation-Sensitizing Agents; Uridine | 2007 |
Radiosensitization of human colorectal tumor cells by 4-nitro-5-sulfonatoimidazoles.
Topics: Adenocarcinoma; Cell Line; Cell Survival; Colorectal Neoplasms; Humans; In Vitro Techniques; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1989 |